Join
Live feed
·
INSIDERFilingvia Quantisnow
Xilio Therapeutics Inc. logo

New insider Gilead Sciences, Inc. claimed ownership of 6,860,223 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
XLO· Xilio Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XLO (Xilio Therapeutics Inc.) and more on Quantisnow.